University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
36 Pages - GLDATA58171
$250.00

Summary

University of Manchester (UOM) is an educational and research institution that offers undergraduate, and post graduate master’s programs. The university offers courses in accounting and finance; aerospace engineering; computer science; cognitive neuroscience and psychology; economics; learning disability; modern languages and cultures; and psychology; among others. It has over various academic schools and academic and research staff. UOM is a part of Russell Group of universities. The university was a merger of Victoria University of Manchester and the University of Manchester Institute of Science and Technology. It is a member of Universities Research Association group. University of Manchester is headquartered in Manchester, the UK.

University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of Manchester, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Manchester, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Manchester, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Manchester, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of Manchester, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
University of Manchester, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 11
OptiBiotix Health and University of Manchester Form Joint Venture 13
AstraZeneca Enters into Co-Development Agreement with University of Manchestery 14
MedImmune Enters into Research Agreement with University of Manchester 15
MedImmune Enters into Research Agreement with COEBP 16
AstraZeneca Forms Joint Venture with University of Manchester 17
Johnson & Johnson Enters into Co-Development Agreement with University of Manchester 18
Blueberry Therapeutics Enters into Agreement with University of Manchester for Antiflammatory Agents 19
GlaxoSmithKline Enters Into Agreement With Cancer Research Technology And University of Manchester For Cancer Drugs 20
Autifony Therapeutics Enters Into Agreement With Universities Of Manchester And Newcastle To Develop Treatment For Schizophrenia 22
Cancer Research Technology, University of Manchester And AstraZeneca Enters Into Agreement To Develop Cancer Drugs 23
Blueberry Therapeutics Enters into Agreement with University of Manchester and University of Liverpool 25
GlaxoSmithKline, AstraZeneca And The University Of Manchester Form Joint Venture 26
Licensing Agreements 28
Acucela Enters into Licensing Agreement with University of Manchester 28
Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors 29
Curapel Enters into Licensing Agreement with University of Manchester 31
Asset Transactions 32
OptiBiotix Health Acquires Rights to Skin Health Intellectual Property from University of Manchester 32
University of Manchester - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
University of Manchester, Pharmaceuticals & Healthcare, Key Facts 1
University of Manchester, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Manchester, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Manchester, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Manchester, Deals By Therapy Area, 2010 to YTD 2016 8
University of Manchester, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 11
OptiBiotix Health and University of Manchester Form Joint Venture 13
AstraZeneca Enters into Co-Development Agreement with University of Manchestery 14
MedImmune Enters into Research Agreement with University of Manchester 15
MedImmune Enters into Research Agreement with COEBP 16
AstraZeneca Forms Joint Venture with University of Manchester 17
Johnson & Johnson Enters into Co-Development Agreement with University of Manchester 18
Blueberry Therapeutics Enters into Agreement with University of Manchester for Antiflammatory Agents 19
GlaxoSmithKline Enters Into Agreement With Cancer Research Technology And University of Manchester For Cancer Drugs 20
Autifony Therapeutics Enters Into Agreement With Universities Of Manchester And Newcastle To Develop Treatment For Schizophrenia 22
Cancer Research Technology, University of Manchester And AstraZeneca Enters Into Agreement To Develop Cancer Drugs 23
Blueberry Therapeutics Enters into Agreement with University of Manchester and University of Liverpool 25
GlaxoSmithKline, AstraZeneca And The University Of Manchester Form Joint Venture 26
Acucela Enters into Licensing Agreement with University of Manchester 28
Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors 29
Curapel Enters into Licensing Agreement with University of Manchester 31
OptiBiotix Health Acquires Rights to Skin Health Intellectual Property from University of Manchester 32
University of Manchester, Key Competitors 33
University of Manchester, Key Employees 34
University of Manchester, Subsidiaries 35

List of Figures
University of Manchester, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Manchester, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Manchester, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Manchester, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Manchester, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Manchester, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
University of Manchester, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Manchester, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838